Agilent Technologies, Inc.

NYSE:A

Medical - Diagnostics & Research

Healthcare
$177.33 +2.44%

+$3.04 today

Market cap
$50.00B
Beta
1.26
P/E (TTM)
25.5
EPS (TTM)
$5.00
Dividend yield
0.59%
52W Low $108.35High $160.27

Volume 2.48M

Average 2.24M

A Weighted Avg Shares

Average number of basic shares outstanding during the period, used to calculate basic EPS.

Agilent Technologies, Inc.NYSE: A

Weighted Avg Shares · Q3 FY2026 · quarter ended Jul 2026

Weighted avg shares declines year over year

Q3 FY2026 weighted avg shares of 282M shares fell 1.1% year over year, in line with the -1.2% change in trailing-twelve-month weighted avg shares. Sequentially, it fell 0.4% from the prior quarter. Over 3 fiscal years it compounded at -1.8% a year.

Context

  • Weighted avg shares increased in 0 of the last 3 fiscal years.
  • FY2025 was the lowest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth of -1.1% holds above the trailing-twelve-month pace of -1.2%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterJul 2026
282M-0.4% QoQ
Last fiscal yearOct 2025
283M-2.4% YoY
LTMJul 2026
282.75M-1.2% YoY
Weighted Avg Shares past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-1.1%——
1 year-2.4%——
3-year CAGR-1.8%——
5-year CAGR——
10-year CAGR——

Weighted Avg Shares history

Shares · from the income statement

Latest · FY2025
283M USD
Year-over-year change
-2.4%
4-year CAGR
-1.8%

Weighted Avg Shares vs competitors

How A compares with its peers on the latest reported figures

  • A's LTM Jul 2026 weighted avg shares of 282.75M shares is the 3rd highest of the 9 companies compared; the peer median is 132.85M shares.
  • Its year-over-year change of -1.2% is the 3rd highest of 9, against a peer median of -2.4%.
  • Over three fiscal years its annual growth of -1.8% compares with a peer median of -1.7%.
A Competitors Peer median
Weighted Avg Shares for A and competitors
Company Period LTM YoY 3-year CAGR
DHRDanaher CorporationLTM Sep 2026706.08M -1.7%-0.8%
TMOThermo Fisher Scientific Inc.LTM Sep 2026372.25M -1.8%-1.4%
AAgilent Technologies, Inc.LTM Jul 2026282.75M -1.2%-1.8%
QGENQiagen N.V.LTM Jun 2026209.5M -4.1%-2.0%
BRKRBruker CorporationLTM Jun 2026152.05M +0.3%+0.7%
RVTYRevvity, Inc.LTM Jul 2026113.64M -5.7%-3.5%
WATWaters CorporationLTM Jul 202674.85M +26.0%-0.3%
BIOBio-Rad Laboratories, Inc.LTM Jun 202626.9M -3.2%-2.9%
MTDMettler-Toledo International Inc.LTM Jun 202620.32M -2.9%-2.9%
Peer median (excluding A) 132.85M-2.4%-1.7%

Competitors are the stored peer set for A. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Oct 2021
FY2022
Oct 2022
FY2023
Oct 2023
FY2024
Oct 2024
FY2025
Oct 2025
Revenue6.32B6.85B6.83B6.51B6.95B
Cost of Revenue2.91B3.13B3.37B2.98B3.31B
Gross Profit3.41B3.72B3.47B3.54B3.64B
Gross Margin53.9%54.4%50.7%54.3%52.4%
Research & Development441M467M481M479M455M
Selling, General & Admin1.62B1.64B1.63B1.52B1.71B
Operating Expenses2.06B2.1B2.12B2.05B2.16B
Depreciation & Amortization321M317M271M257M288M
EBITDA1.76B1.91B1.7B1.87B1.84B
EBITDA Margin27.9%27.8%24.9%28.8%26.4%
Operating Income1.35B1.62B1.35B1.49B1.48B
Operating Margin21.3%23.6%19.8%22.9%21.3%
Interest Income2M9M51M80M62M
Interest Expense81M84M95M96M112M
Other Income / Expenses13M(114M)(11M)33M(44M)
Income Before Tax1.36B1.5B1.34B1.52B1.44B
Pre-Tax Margin21.5%22.0%19.6%23.4%20.7%
Income Tax Expense150M250M99M232M132M
Net Income1.21B1.25B1.24B1.29B1.3B
Net Margin19.1%18.3%18.1%19.8%18.8%
EPS (Basic)3.984.194.224.444.59
EPS (Diluted)3.944.184.194.434.57
Weighted Avg Shares304M299M294M290M283M
Weighted Avg Shares (Diluted)307M300M296M291M284M

Agilent Technologies, Inc.

NYSE:A

Intrinsic Alpha fair value

Locked

Current Price

$177.33

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.